This placebo-controlled study investigates acetyl-L-carnitine in the treatment of septic
shock requiring vasopressors.
This is a cross-over study which infuses ALC for 12 out of 18 hours (and placebo the other
6). Patients must have vasopressor-dependent septic shock and be free from renal failure,
hepatic failure, and seizures to be eligible.
- documented or presumed infection
- shock requiring vasopressors
- hepatic failure